Yunye Liu
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The immune enhancement effects of recombinant NDV expressing chicken granulocyte-macrophage colony-stimulating factor on the different avian influenza vaccine subtypes.
Journal: Transboundary and emerging diseases
Published: October 28, 2019
Correction: Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect.
Journal: PloS one
Published: January 31, 2017
Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect.
Journal: PloS one
Published: June 11, 2016
Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-κB signaling pathway.
Journal: International immunopharmacology
Published: March 11, 2016
Recombinant NDV expressing cytokines or fliC confers a quick immune response against NDV challenge and resistance to maternal antibody.
Journal: Veterinary microbiology
Published: January 16, 2016
Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model.
Journal: Journal of biomedical science
Published: December 14, 2015
Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway.
Journal: Endocrine
Published: July 31, 2015
Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy.
Journal: Technology in cancer research & treatment
Published: February 09, 2015
Fibroblast growth factor (FGF21) protects mouse liver against D-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways.
Journal: Molecular and cellular biochemistry
Published: October 08, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026